TENAX THERAPEUTICS, INC. short interest in 2024
In 2024, TENAX THERAPEUTICS, INC.'s disclosed short interest ran from 2.50% of shares outstanding on 28 Mar 2024 to 6.40% on 31 Dec 2024, a change of +3.90 percentage points. The year's high was 6.40% on 31 Dec 2024 and its low 0.33% on 31 May 2024, averaging 2.16% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.11 days on 31 Dec 2024. Full history: TENAX THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 2.50% (28 Mar 2024)
- End of year
- 6.40% (31 Dec 2024)
- Change
- +3.90 pp
- High
- 6.40% (31 Dec 2024)
- Low
- 0.33% (31 May 2024)
- Average
- 2.16%
- Highest days to cover
- 5.11 (31 Dec 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Mar 2024 | 2.50% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 1.80% | 1.00 | |
| 30 Apr 2024 | 1.14% | 1.00 | |
| 15 May 2024 | 0.50% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2024 | 0.33% | 1.00 | |
| 14 Jun 2024 | 0.51% | 1.00 | |
| 28 Jun 2024 | 0.60% | 1.00 | |
| 15 Jul 2024 | 1.22% | 1.23 | |
| 31 Jul 2024 | 0.53% | 1.00 | |
| 15 Aug 2024 | 3.40% | 1.00 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 2.67% | 1.63 | |
| 13 Sep 2024 | 1.48% | 1.55 | |
| 30 Sep 2024 | 0.85% | 1.00 | |
| 15 Oct 2024 | 0.62% | 1.00 | |
| 31 Oct 2024 | 3.10% | 1.00 | |
| 15 Nov 2024 | 3.55% | 1.98 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 3.83% | 2.31 | |
| 13 Dec 2024 | 6.00% | 2.48 | |
| 31 Dec 2024 | 6.40% | 5.11 |
See also: TENAX THERAPEUTICS, INC.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.